Tag: Janssen


Promising Trial Results of Drug to treat RSV Published in the New England Journal of Medicine

|

A new antiviral drug, ALS-008176, designed to fight respiratory syncytial virus (RSV) has shown potential against RSV infection. The medicine, developed by Alios Biopharma Inc., one of the Janssen Pharmaceutical Companies, in collaboration with laboratories at Le Bonheur Children’s Hospital and physicians from the University of Tennessee Health Science Center, could re-define how physicians worldwide… Read More